Avarol (50 mg/kg; i.p.; daily for 14 days) shows anti-tumor activity in mice[1].
| Animal Model: | female F1 (CBA × C57BL/6j) mice (Ehrlich carcinoma)[1] |
| Dosage: | 50 mg/kg |
| Administration: | I.p.; daily for 14 days |
| Result: | Inhibited tumor growth with a stable inhibition (25-35%) of EC growth. |
